Quick Answer
Can-Fite BioPharma Ltd. reported Stockholders Equity of $5.59 million for the year ending 2025.
- Can-Fite BioPharma Ltd. showed an increase of +2.9% in Stockholders Equity from 2024 to 2025.
- This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Can-Fite BioPharma Ltd.'s Stockholders Equity has grown by 87.4%.
- Historical annual values: Fiscal year 2025: $5.59 million | Fiscal year 2024: $5.44 million | Fiscal year 2023: $6.24 million | Fiscal year 2022: $4.47 million | Fiscal year 2021: $14.38 million | Fiscal year 2020: $6.07 million | Fiscal year 2019: $2.44 million | Fiscal year 2018: $3.02 million | Fiscal year 2017: $2.98 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: